{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:49:48Z","timestamp":1785790188305,"version":"3.56.0"},"reference-count":16,"publisher":"Health Affairs Publishing, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Affairs"],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.1377\/hlthaff.2026.00334","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:55:37Z","timestamp":1785786937000},"page":"855-861","source":"Crossref","is-referenced-by-count":0,"title":["Profitability Of Infused Biologics For Hospitals And Physician Practices: Case Study Of Keytruda"],"prefix":"10.1377","volume":"45","author":[{"given":"James C.","family":"Robinson","sequence":"first","affiliation":[{"name":"James C. Robinson (), University of California Berkeley, Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Kosorukuv","sequence":"additional","affiliation":[{"name":"Ari Kosorukuv, Brown University, Providence, Rhode Island."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thomson","sequence":"additional","affiliation":[{"name":"Mark Thomson, University of California Berkeley."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Whaley","sequence":"additional","affiliation":[{"name":"Christopher M. Whaley, Brown University."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"102","reference":[{"key":"B1","unstructured":"Department of Health and Human Services. Fact sheet: bringing lower-cost biosimilar drugs to American patients [Internet]. Washington (DC): HHS; [last reviewed 2025 Oct 29; cited 2026 Jul 20]. Available from: https:\/\/www.hhs.gov\/press-room\/fact-sheet-bringing-lower-cost-biosimilar-drugs-to-american-patients.html"},{"key":"B2","unstructured":"3 Axis Advisors. Analysis of prescription drug prices in hospitals [Internet]. Columbus (OH): 3 Axis Advisors; 2026 Mar 5 [cited 2026 Jun 18]. Available from: https:\/\/www.3axisadvisors.com\/projects\/2026\/3\/5\/analysis-of-prescription-drug-prices-in-hospitals"},{"key":"B3","unstructured":"Government Accountability Office. 340B Drug Discount Program: information about hospitals that received an eligibility exception as a result of COVID-19 [Internet]. Washington (DC): GAO; 2023 May 11 [cited 2026 Jul 20]. (Report No. GAO-23-106095). Available from: https:\/\/www.gao.gov\/assets\/gao-23-106095.pdf"},{"key":"B4","unstructured":"Buntz B. 2024\u2019s blockbusters: top 50 drugs by sales. Drug Discovery and Development [serial on the Internet]. 2025 Apr 4 [cited 2026 Jun 18]. Available from: https:\/\/www.drugdiscoverytrends.com\/2024s-blockbusters-top-50-pharmaceuticals-by-sales\/"},{"key":"B5","unstructured":"Freedberg SP, Medina B, Ajiri D. How Merck turned its wonder drug into a blockbuster\u2014and priced out cancer patients worldwide. International Consortium of Investigative Journalists [serial on the Internet]. 2026 Apr 13 [cited 2026 Jun 18]. Available from: https:\/\/www.icij.org\/investigations\/cancer-calculus\/merck-keytruda-cancer-drug-price\/"},{"key":"B6","unstructured":"Merck and Company [Internet]. Rahway (NJ): Merck and Company; c 2026. Press release, Merck announces fourth quarter and full-year 2024 financial results; 2025 Feb 4 [cited 2026 Jun 18]. Available from: https:\/\/www.merck.com\/news\/merck-announces-fourth-quarter-and-full-year-2024-financial-results\/"},{"key":"B7","unstructured":"Minnesota Department of Health. 340B covered entity report: report to the Minnesota legislature, 2025 [Internet]. Saint Paul (MN): The Department; 2026 Feb 27 [cited 2026 Jun 18]. Available from: https:\/\/www.health.state.mn.us\/data\/340b\/docs\/2025report.pdf"},{"key":"B8","unstructured":"Blue Cross Blue Shield Association. Blue Cross Blue Shield Association  announces industry-leading healthcare data capability to drive improved quality and affordable care [Internet]. Chicago (IL): BCBSA; 2015 Sep 24 [cited 2026 Jul 20]. Available from: https:\/\/www.prnewswire.com\/news-releases\/blue-cross-blue-shield-association-announces-industry-leading-healthcare-data-capability-to-drive-improved-quality-and-affordable-care-300148479.html"},{"key":"B9","unstructured":"Wennberg JE, Cooper MM, editors. The Dartmouth atlas of health care 1998 [Internet]. Chicago (IL): American Hospital Publishing; 1998 [cited 1 Jul 2026]. Available from: https:\/\/data.dartmouthatlas.org\/downloads\/atlases\/98Atlas.pdf"},{"key":"B10","unstructured":"Centers for Medicare and Medicaid Services. Medicare Part B drug average sales price [Internet]. Baltimore (MD): CMS; [last modified 2026 Apr 8; cited 2026 Jun 18]. Available from: https:\/\/www.cms.gov\/medicare\/payment\/fee-for-service-providers\/part-b-drugs\/average-drug-sales-price"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13281"},{"issue":"156","key":"B12","first-page":"48772","volume":"85","year":"2020","journal-title":"Fed Regist"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.1777"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/00469580251324051"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2021.00211"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2306609"}],"container-title":["Health Affairs"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:56:03Z","timestamp":1785786963000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2026.00334"}},"subtitle":["Article examines the profitability of infused biologics for hospitals and physician practices via a case study of Keytruda"],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"alternative-id":["10.1377\/hlthaff.2026.00334"],"URL":"https:\/\/doi.org\/10.1377\/hlthaff.2026.00334","relation":{},"ISSN":["0278-2715","1544-5208"],"issn-type":[{"value":"0278-2715","type":"print"},{"value":"1544-5208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}